News September 16, 2019 USM is investing $250k in a product designed to heal skin wounds – The Diamondback The University System of Maryland recently invested $250,000 in a University of Maryland alumna’s biotech… Super User 0 Love0
News September 16, 2019 RegenxBio reaches licensing deal with Clearside Biomedical – Washington Business Journal RegenxBio Inc. just locked in another deal — this one with a company working to… Super User 0 Love0
News September 16, 2019 FDA Approval of Roche Cancer Drug Confirms Beginning of New Oncology Era | The Motley Fool With nothing more than a passing glance, the U.S. Food & Drug Administration's (FDA) approval… Super User 0 Love0
News September 16, 2019 First hint that body’s ‘biological age’ can be reversed A small clinical study in California has suggested for the first time that it might… Super User 0 Love0
News September 16, 2019 Baltimore-based Capsulomics wins first place at Patriot Boot Camp in Utah – Technical.ly Baltimore Baltimore-based Capsulomics won the top award in Utah last month at a pitch competition that… Super User 0 Love0
News September 16, 2019 Maryland Startup Developing AI-Enabled Drug Discovery Technology, Insilico Medicine, Just Raised $37M in Funding from Leading Chinese VC Firm · BioBuzz In the world of drug discovery and development, there is increasing pressure to get novel… Super User 0 Love0
News September 16, 2019 What Does It Take to Build A Globally Competitive Biohealth Cluster? · BioBuzz The BioHealth Capital Region (BHCR) continues to thrive and currently occupies the fourth spot in… Super User 0 Love0
News September 16, 2019 United Therapeutics Announces FDA Acceptance Of Trevyent New Drug Application For Review United Therapeutics Corporation (UTHR) today announced that the U.S. Food and Drug Administration (FDA) has… Super User 0 Love0
News September 16, 2019 How Top Companies Attract, Engage and Retain Their BioHealth Workforce · BioBuzz Are you finding it harder to recruit, hire and retain the biotech workforce you need?… Super User 0 Love0
News September 16, 2019 Viela Bio IPO: At Phase 3 Of Development With Positive Results – VIELA BIO, INC. (Pending:VIE) | Seeking Alpha With product candidates acquired from AstraZeneca (AZN) and MedImmune, Viela Bio (VIE) is clinical-stage biotechnology… Super User 0 Love0